Copied
 
 
Formål
Formål
Selskabets formål er at drive virksomhed med forskning og fabrikation af samt handel med lægemidler, kemikalier og lignende, samt efter bestyrel-sens skøn at drive anden i forbindelse dermed stående virksomhed. Sel-skabet tilstræber at drive sin virksomhed på økonomisk, miljømæssigt og socialt ansvarlig vis.
Sidst opdateret den 18.02.2015 og angivet som gældende fra 18.02.2015 (3359 dage).
Ingen historik.
Status
Virksomhedsstatus
NORMAL.
Sidst opdateret den 18.02.2015 og angivet som gældende fra 14.10.1950 (26862 dage).
Ingen historik.
Branche
Branche
Fremstilling af farmaceutiske præparater (212000).
Sidst opdateret den 28.12.2007 og angivet som gældende fra 01.01.2008 (5964 dage).
HistorikStartStop
Fremstilling af farmaceutiske præparater (212000)01.01.2008
Medicinalvarefabrikker (244200)14.10.195031.12.2007
Revision
Revisionfravalgt
false.
Sidst opdateret den 11.03.2015 og angivet som gældende fra 14.10.1950 (26862 dage).
Ingen historik.
Revisor
Revisor
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
Sidst opdateret den 31.03.2020 og angivet som gældende fra 24.03.2020 (1498 dage).
HistorikStartStop
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB24.03.2020
DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB13.10.201124.03.2020
Green IV ApS14.12.199822.04.2008
DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB17.05.199513.10.2011
Søren Bjerre-Nielsen.14.10.195017.05.1995
Martin Vilhelm Lind.14.10.195003.10.1988
Form
Virksomhedsform
60.
Sidst opdateret den 22.11.2013 og angivet som gældende fra 14.10.1950 (26862 dage).
Ingen historik.
Kontakt
HistorikStartStop
information@lundbeck.com23.01.200009.12.2004
Virksomheden har ikke ændret Kontakt i sin levetid.
Ingen nuværende registrering.
Telefon
Telefonnummer
36301311.
Sidst opdateret den 01.04.2000 og angivet som gældende fra 23.01.2000 (8864 dage).
Ingen historik.
Navne
Ingen historik.
Binavne
Binavne
KEFALAS A/S.
Sidst opdateret den 18.02.2015 og angivet som gældende fra 14.10.1950 (26862 dage).
HistorikStartStop
KEFALAS A/S14.10.1950
KEFALAS A/S14.10.195020.04.2010
Tegningsregel
Tegningsregel
Selskabet tegnes af fire bestyrelsesmedlemmer i forening eller af to direktører i forening eller af et bestyrelsesmedlem og en direktør i forening.
Sidst opdateret den 18.02.2015 og angivet som gældende fra 18.02.2015 (3359 dage).
Fortolkning (3 tegningsmuligheder)
4 bestyrelsesmedlemmer +
2 direktører +
1 bestyrelsesmedlem + 1 direktør
Ingen historik.
Ansatte
30.04.2024
Kapital
30.04.2024
Fra årsrapport
Type af revisorbistand:Auditor's report on audited financial statements
Navn på revisionsvirksomhed:PricewaterhouseCoopers
Revisionsvirksomhedens CVR-nr.:33771231
Beskrivelse af revisor:State Authorized Public Accountant
Virksomhedens regnskabsklasse:Reporting class D
Grundlag for konklusion (revision):We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards andrequirements are further described in the Auditor’s responsibilities for the audit of the Financial Statements section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Independence We are independent of the Group in accordance with the International Ethics Standards Board forAccountants’ International Code of Ethics forProfessional Accountants (IESBA Code) and the additional ethical requirements applicable inDenmark. We have also fulfilled our other ethical responsibilities in accordance with theserequirements and the IESBA Code. To the best of our knowledge and belief, prohibited non-audit services referred to in Article 5(1) of Regulation (EU) No 537/2014 were not provided. Appointment We were first appointed auditors of H. Lundbeck A/S on 24 March 2020 for the financial year 2020. We have been reappointed annually by shareholder resolution for a total period of uninterruptedengagement of 4 years including the financial year 2023.
Konklusion (revision):In our opinion, the Consolidated Financial Statements (pages 50-91) give a true and fair view of the Group’s financial position at 31 December 2023 and of the results of the Group’s operations and cash flows for the financial year 1 January to 31 December 2023 in accordance with IFRS Accounting Standards as adopted by the EU and further requirements in the Danish Financial Statements Act. Moreover, in our opinion, the Parent Company Financial Statements (pages 92-101) give a true and fair view of the Parent Company’s financial position at 31 December 2023 and of the results of the Parent Company’s operations for the financial year 1 January to 31 December 2023 in accordance with the Danish Financial Statements Act. Our opinion is consistent with our Auditor’s Long-form Report to the Audit Committee and the Board of Directors. What we have audited The Consolidated Financial Statements of H. Lundbeck A/S for the financial year 1 January to 31 December 2023 comprise the consolidated statement of profit or loss and statement of comprehensive income, the consolidated statement of financial position, the consolidated statement of changes in equity, the consolidated statement of cash flows and the notes, including summary of material accounting policy information. The Parent Company Financial Statements of H. Lundbeck A/S for the financial year 1 January to 31 December 2023 comprise the statement of profit or loss, the statement of financial position, the statement of changes in equity, and the notes, including summary of material accounting policy information. Collectively referred to as the “Financial Statements”.
Udtalelse om ledelsesberetningen (revision):Management is responsible for Management Review (pages 3-48 and page 107, respectively). Our opinion on the Financial Statements døs not cover Management Review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the Financial Statements, our responsibility is to read Management Review and, in doing so, consider whetherManagement Review is materially inconsistent with the Financial Statements or our knowledge obtained in the audit, or otherwise appears to be materially misstated. Moreover, we considered whether Management Review includes the disclosures required by the Danish Financial Statements Act and Article 8 of Regulation (EU) 2020/852 (EU TaxonomyRegulation). Based on the work we have performed, in our view, Management Review is in accordance with the Consolidated Financial Statements and the Parent Company Financial Statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act and the disclosure requirements of Article 8 of Regulation (EU) 2020/852 (EU Taxonomy Regulation). We did not identify any material misstatement in Management Review.
Bibranche
Bibranche
Engroshandel med medicinalvarer og sygeplejeartikler.
Sidst opdateret den 07.01.2008 og angivet som gældende fra 01.01.2008 (5964 dage).
HistorikStartStop
Engroshandel med medicinalvarer og sygeplejeartikler01.01.2008
Engroshandel med medicinalvarer og sygeplejeartikler14.10.195030.12.2007
Børsnoteret
30.04.2024
Børsnoteret
true.
Sidst opdateret den 18.02.2015 og angivet som gældende fra 01.01.2005 (7059 dage).
Ingen historik.
Hjemmeside
30.04.2024
Ingen nuværende registrering.
Ingen historik.